Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.

Johnson & Johnson applies for vaccine authorisation in India

When Johnson & Johnson’s single-dose coronavirus vaccine was authorized for emergency use in late February, it was seen as a breakthrough for reaching vulnerable and isolated Americans, a crucial alternative to vaccines that require two shots weeks apart and fussier storage.

High hopes for Johnson & Johnson’s COVID vaccine have fizzled in the US

While the third-world countries are struggling to get coronavirus vaccine, a factory in the US ruined nearly 15 million doses of the Johnson & Johnson coronavirus vaccines.

US: 15 million doses of Johnson & Johnson coronavirus vaccine destroyed